According to the report “Europe Cervical Cancer Diagnostics and Therapeutics Market,” published by Market Data Forecast, the global market is projected to reach USD 1129.72 million by 2021 from USD 955.80 million in 2016, at a CAGR of 3.40% from 2016 to 2021.
Cervical cancer occurs when abnormal cells on the cervix grow out of control. The cervix is the lower part of the uterus that opens into the vagina. Cervical cancer can often be successfully treated when it’s found early. It is usually found at a very early stage through a Pap test.
Get accurate market forecast and analysis on the Europe Cervical Cancer Diagnostics and Therapeutics market. Request a free sample to stay up-to-date on the main trends affecting this market http://www.marketdataforecast.com/market-reports/europe-cervical-cancer-diagnostics-and-therapeutics-market-831/request-sample
Most cervical cancer is caused by a virus called human papillomavirus, or HPV. You can get HPV by having sexual contact with someone who has it. There are many types of the HPV virus. Not all types of HPV cause cervical cancer. Some of them cause genital warts, but other types may not cause any symptoms.
Most adults have been infected with HPV at some time. An infection may go away on its own. But sometimes it can cause genital warts or lead to cervical cancer. That’s why it’s important for women to have regular Pap tests. A Pap test can find changes in cervical cells before they turn into cancer. If you treat these cell changes, you may prevent cervical cancer.
Europe Cervical Cancer Diagnostics and Therapeutics market: Drivers & Restraints
The market for Europe Cervical Cancer Diagnostics and Therapeutics is mainly driven by increase of pipeline cervical cancer screening tests and also due to effective government initiatives for both treatment and prevention of cancer. But, due to the high treatment costs and uncertain reimbursement scenario, the market growth is hampered.
Get comprehensive overviews of the Europe Cervical Cancer Diagnostics and Therapeutics market: http://www.marketdataforecast.com/market-reports/europe-cervical-cancer-diagnostics-and-therapeutics-market-831/
Europe Cervical Cancer Diagnostics and Therapeutics market: Segmentation
By diagnostics test
- Pap smear test
- HPV testing
- Cervical cancer biopsy
- Molecular method
- Cytopathological method
- Physical method
- Radiation therapy
- Other therapies
- Independent physicians
- Other end-users
From simple data collation through secondary and primary research toad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/europe-cervical-cancer-diagnostics-and-therapeutics-market-831/customize-report
Europe Cervical Cancer Diagnostics and Therapeutics market: Overview
Cervical cancer was once one of the most common causes of cancer death for American women. But over the last 40 years, the cervical cancer death rate has gone down by more than 50%. The main reason for this change was the increased use of the Pap test. This screening procedure can find changes in the cervix before cancer develops. It can also find cervical cancer early in its most curable stage. Cervical cancer tends to occur in midlife. Most cases are found in women younger than 50. It rarely develops in women younger than 20. Many older women do not realize that the risk of developing cervical cancer is still present as they age. More than 15% of cases of cervical cancer are found in women over 65. However these cancers rarely occur in women who have been getting regular tests to screen for cervical cancer before they were 65.
Pap smear test segment dominated the market by Diagnostic test, holding a 45% share in the global market for cervical cancer diagnostic tests. The high growth rate of this segment can be attributed to the high efficiency of the test, low cost of the test in comparison with other tests available in the market, and rising awareness regarding cancer diagnosis.
Europe Cervical Cancer Diagnostics and Therapeutics market: Region-wise Outlook
Geographically, Europe market for Cervical Cancer Diagnostics and Therapeutics is segmented into U.K, Germany, Spain, France and Italy. With high investment in R & D, a lot of companies are interested in setting up their units in this region, where they find a potential future.
Key Questions Answered
- What is the current and future Cervical Cancer Diagnostics and Therapeutics market outlook worldwide? What trends are affecting the Europe market?
- What is the competitive landscape and market share of major players in the Cervical Cancer Diagnostics and Therapeutics space in Europe?
- What are the key, high growth markets that Cervical Cancer Diagnostics and Therapeutics manufacturers should expand into? Which market segments are growing the fastest?
- What are the unmet needs with the Cervical Cancer Diagnostics and Therapeutics currently on the market? How will emerging technologies fulfil these unmet needs?
- What is physician perception and market outlook of Cervical Cancer Diagnostics and Therapeutics?
- What are the challenges and barriers that have hindered widespread adoption of Cervical Cancer Diagnostics and Therapeutics?
Europe Cervical Cancer Diagnostics and Therapeutics market: Key Players
Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, EDP Biotech, Epigenomics AG, Exact Sciences, Fujirebio, Genomic Tree, Metabiomics, Oncocyte (Biotime), Quest Diagnostics, Randox Laboratories, Siemens Healthcare, Volition Rx, are the major players of Europe Cervical Cancer Diagnostics and Therapeutics market.
Reasons to buy Europe Cervical Cancer Diagnostics and Therapeutics market Report:
- Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
- Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
- Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
- Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
- A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
- Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
- Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Therapeutics Segment:
Europe Prostate Cancer Market: http://www.marketdataforecast.com/market-reports/europe-prostate-cancer-market-1618/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases